To study the Prevalence and Outcomes of Sepsis-induced Cardiomyopathy (SICM) in an Intensive Care Unit
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- To determine the prevalence and outcome of Sepsis induced cardiomyopathy in the ICU
研究概览
简要总结
In this non-randomised observational study, all patients with diagnosis of suspected sepsis admitted to the ICU will be selected. Sepsis will be defined according to the Third International Consensus Definitions for Sepsis and Septic shock; SOFA score will be used to identify organ dysfunction. Along with baseline parameters, transthoracic echocardiography will be done to assess the presence of cardiomyopathy in all such patients. Thereafter, patients will be divided into 2 groups: Group 1 comprising all those without cardiomyopathy and Group 2 comprising all those with cardiomyopathy. Baseline characteristics, per-existing comorbidities, need for inotropic support, mechanical ventilation and/or tracheostomy will be compared along with duration of ICU stay and mortality .
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having sepsis or septic shock admitted in the ICU.
排除标准
- •Patients whose diagnostic criteria does not fulfill sepsis or septic shock, patients shifted to ICU after elective surgeries, pregnant patients.
结局指标
主要结局
To determine the prevalence and outcome of Sepsis induced cardiomyopathy in the ICU
时间窗: 2 years
次要结局
- To assess the need of inotropic support, mechanical ventilation and/ or tracheostomy(During ICU stay)